The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search feed instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content
| Childers, Schlueter & Smith

The FDA is now warning of new dangers associated with Ketek, the first antibiotic of the ketolide class. Primarily used in treatment for chronic bronchitis, acute bacterial sinusitis and varying levels types of pneumonia, Ketek has been linked to rare cases of serious liver injury and liver failure. At least four confirmed deaths have been linked to the drug. To address these issues, the manufacturer, Sanofi Aventis, has now revised its warning label.

Comments are closed.